More on UPB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/28/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

UpstreamBio (NQ:UPB)
Delayed: 7.66 -0.01 (0.13%)
Prev. Close $7.67  
Open$7.47 
52 Wk High$ 
52 Wk Low$ 
Day High$7.77 
Day Low$7.40 
P/E N/A  
EPS$ 
Volume702,478 

Friends, Peers and Foes (?): BCAX, ARGX, BBIO, CNTA, BBNX (more...)

Mar 1, 2026 09:45 AM Upstream Bio presents additional Phase 2 data for nasal polyp treatment
Mar 1, 2026 09:45 AM Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
Feb 26, 2026 07:00 AM Upstream Bio to present Phase 2 trial data at AAAAI meeting
Feb 26, 2026 07:00 AM Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Feb 25, 2026 07:00 AM Upstream Bio to Participate in Upcoming March Investor Conferences
Feb 11, 2026 09:17 AM Form 8-K Upstream Bio, Inc. For: Feb 11
Feb 11, 2026 09:17 AM Form 8-K Upstream Bio, Inc. For: Feb 11
Feb 11, 2026 08:55 AM Upstream Bio (UPB) data was positive but not 'home run', says TD Cowen
Feb 11, 2026 06:39 AM Form 8-K Upstream Bio, Inc. For: Feb 11
Feb 11, 2026 06:00 AM Upstream Bio reports positive Phase 2 trial results for severe asthma drug
View All Articles

Entities mentioned with UPB

View All Entities